Stay updated on Dapagliflozin-Induced Liver Injury Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.

Latest updates to the Dapagliflozin-Induced Liver Injury Clinical Trial page
- Check5 days agoChange DetectedThe page now shows a 403 Forbidden error page with basic navigation, indicating access is blocked. The previously visible study content and related sections such as CSR Synopsis, AstraZeneca details, and IPD sharing information were removed.SummaryDifference15%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the page.SummaryDifference0.1%

- Check47 days agoChange DetectedFooter version updated from v3.6.4 to v3.6.5, indicating a minor platform update with no changes to study information.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating a site-wide software update. This appears to be a backend release that does not modify the study details or displayed content.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page header, signaling a small update to the published page without changing the study information.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page's revision tag updated from v3.6.0 to v3.6.2, indicating a backend or UI update with no visible changes to the study information.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin-Induced Liver Injury Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin-Induced Liver Injury Clinical Trial page.